-
1
-
-
0032189666
-
Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and Other Societies on Coronary Prevention
-
(1998)
Eur Heart J
, vol.19
, pp. 1434-1503
-
-
-
3
-
-
0030604595
-
1996 National Heart Foundation clinical guidelines for the assessment and management of dyslipidaemia
-
(1996)
N Z Med J
, vol.109
, pp. 224-231
-
-
-
4
-
-
0027987849
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
-
(1994)
Lancet
, vol.344
, pp. 1383-1389
-
-
-
5
-
-
0028883828
-
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
-
(1995)
N Engl J Med
, vol.333
, pp. 1301-1307
-
-
Shepherd, J.1
Cobbe, S.M.2
Ford, I.3
Isles, C.G.4
Lorimer, A.R.5
MacFarlane, P.W.6
McKillop, J.H.7
Packard, C.J.8
-
6
-
-
0342981862
-
The effect of pravastatin on cholesterol events
-
(1996)
N Engl J Med
, vol.335
, pp. 1001-1009
-
-
Sacks, F.M.1
Pfeffer, M.A.2
Moyé, L.A.3
Rouleau, J.L.4
Rutherford, J.D.5
Cole, T.G.6
Brown, L.7
Warnica, J.W.8
Arnold, J.M.O.9
Wun, C.C.10
Davis, B.R.11
Braunwald, E.12
-
7
-
-
0032572086
-
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study
-
(1998)
JAMA
, vol.279
, pp. 1615-1622
-
-
Downs, J.R.1
Clearfield, M.2
Weis, S.3
Whitney, E.4
Shapiro, D.R.5
Beere, P.A.6
Langendorfer, A.7
Stein, E.A.8
Kruyer, W.9
Gotto Jr., A.M.10
-
8
-
-
0032487931
-
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
-
(1998)
N Engl J Med
, vol.339
, pp. 1349-1357
-
-
-
9
-
-
0029838433
-
Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies
-
(1996)
J Cardiovasc Risk
, vol.3
, pp. 213-219
-
-
Hokanson, J.E.1
Austin, M.A.2
-
12
-
-
0023232216
-
Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease
-
(1987)
N Engl J Med
, vol.317
, pp. 1237-1245
-
-
Frick, M.H.1
Elo, O.2
Haapa, K.3
Heinonen, O.P.4
Heinsalmi, P.5
Helo, P.6
Huttunen, J.K.7
Kaitaniemi, P.8
Koskinen, P.9
Manninen, V.10
-
13
-
-
0034604225
-
Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: The Bezafibrate Infarction Prevention (BIP) study
-
(2000)
Circulation
, vol.102
, pp. 21-27
-
-
-
14
-
-
0033527030
-
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
-
Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group
-
(1999)
N Engl J Med
, vol.341
, pp. 410-418
-
-
Rubins, H.B.1
Robins, S.J.2
Collins, D.3
Fye, C.L.4
Anderson, J.W.5
Elam, M.B.6
Faas, F.H.7
Linares, E.8
Schaefer, E.J.9
Schectman, G.10
Wilt, T.J.11
Wittes, J.12
-
15
-
-
0029161830
-
HDL cholesterol predicts coronary heart disease mortality in older persons
-
(1995)
JAMA
, vol.274
, pp. 539-544
-
-
Corti, M.C.1
Guralnik, J.M.2
Salive, M.E.3
Harris, T.4
Field, T.S.5
Wallace, R.B.6
Berkman, L.F.7
Seeman, T.E.8
Glynn, R.J.9
Hennekens, C.H.10
-
17
-
-
0032497945
-
Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels. Subgroup analyses in the Cholesterol and Recurrent Events (CARE) Trial
-
(1998)
Circulation
, vol.98
, pp. 2513-2519
-
-
Goldberg, R.B.1
Mellies, M.J.2
Sacks, F.M.3
Moyé, L.A.4
Howard, B.V.5
Howard, W.J.6
Davis, B.R.7
Cole, T.G.8
Pfeffer, M.A.9
Braunwald, E.10
-
18
-
-
0002753305
-
Clinical practice recommendations 2001
-
(2001)
Diabetes Care
, vol.24
, Issue.SUPPL. 1
-
-
|